步长制药：8月15日召开董事会会议

Group 1 - Company Bichang Pharmaceutical (SH 603858) announced on August 15 that its 29th meeting of the fifth board of directors was held via communication, discussing the proposal to sign an agreement with Shandong University of Traditional Chinese Medicine Affiliated Hospital regarding the optimization of the menstrual regulation formula [2] - For the year 2024, Bichang Pharmaceutical's revenue composition is as follows: 99.71% from the pharmaceutical industry and 0.29% from other businesses [2]